203 related articles for article (PubMed ID: 30089729)
1. Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans.
Morville T; Sahl RE; Trammell SA; Svenningsen JS; Gillum MP; Helge JW; Clemmensen C
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089729
[TBL] [Abstract][Full Text] [Related]
2. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women.
Mercer KE; Maurer A; Pack LM; Ono-Moore K; Spray BJ; Campbell C; Chandler CJ; Burnett D; Souza E; Casazza G; Keim N; Newman J; Hunter G; Fernadez J; Garvey WT; Harper ME; Hoppel C; Adams SH; Thyfault J
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E864-E873. PubMed ID: 33645254
[TBL] [Abstract][Full Text] [Related]
3. Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.
Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
J Intern Med; 2018 Nov; 284(5):546-559. PubMed ID: 29964306
[TBL] [Abstract][Full Text] [Related]
4. Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans.
Meyer-Gerspach AC; Steinert RE; Keller S; Malarski A; Schulte FH; Beglinger C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3351-8. PubMed ID: 23783097
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.
Thöni V; Pfister A; Melmer A; Enrich B; Salzmann K; Kaser S; Lamina C; Ebenbichler CF; Hackl H; Tilg H; Moschen AR
J Clin Endocrinol Metab; 2017 Aug; 102(8):2974-2984. PubMed ID: 28591793
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of a 40-hour fast and bile acid supplementation on human GLP-1 and FGF19 responses.
van Nierop FS; Meessen ECE; Nelissen KGM; Achterbergh R; Lammers LA; Vaz FM; Mathôt RAA; Klümpen HJ; Olde Damink SW; Schaap FG; Romijn JA; Kemper EM; Soeters MR
Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E494-E502. PubMed ID: 31237451
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202
[No Abstract] [Full Text] [Related]
8. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
[TBL] [Abstract][Full Text] [Related]
9. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans.
Morton GJ; Kaiyala KJ; Foster-Schubert KE; Cummings DE; Schwartz MW
J Clin Endocrinol Metab; 2014 Feb; 99(2):E241-5. PubMed ID: 24297792
[TBL] [Abstract][Full Text] [Related]
11. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations.
Sánchez-Infantes D; Gallego-Escuredo JM; Díaz M; Aragonés G; Sebastiani G; López-Bermejo A; de Zegher F; Domingo P; Villarroya F; Ibáñez L
Int J Obes (Lond); 2015 May; 39(5):742-6. PubMed ID: 25599612
[TBL] [Abstract][Full Text] [Related]
12. An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.
Al-Khaifi A; Rudling M; Angelin B
Gastroenterology; 2018 Oct; 155(4):1012-1016. PubMed ID: 29928896
[TBL] [Abstract][Full Text] [Related]
13. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
[TBL] [Abstract][Full Text] [Related]
14. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
Lundåsen T; Gälman C; Angelin B; Rudling M
J Intern Med; 2006 Dec; 260(6):530-6. PubMed ID: 17116003
[TBL] [Abstract][Full Text] [Related]
15. FGF19 subfamily members: FGF19 and FGF21.
Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
[TBL] [Abstract][Full Text] [Related]
16. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
[TBL] [Abstract][Full Text] [Related]
17. A bout of endurance and resistance exercise transiently decreases plasma levels of bile acids in young, sedentary adults.
Osuna-Prieto FJ; Jurado-Fasoli L; Plaza-Florido A; Yang W; Kohler I; Di X; Rubio-López J; Sanchez-Delgado G; Rensen PCN; Ruiz JR; Martinez-Tellez B
Scand J Med Sci Sports; 2023 Sep; 33(9):1607-1620. PubMed ID: 37278109
[TBL] [Abstract][Full Text] [Related]
18. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism.
Cariello M; Piglionica M; Gadaleta RM; Moschetta A
Handb Exp Pharmacol; 2019; 256():73-93. PubMed ID: 31123830
[TBL] [Abstract][Full Text] [Related]
19. Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.
Barrera F; Azócar L; Molina H; Schalper KA; Ocares M; Liberona J; Villarroel L; Pimentel F; Pérez-Ayuso RM; Nervi F; Groen AK; Miquel JF
Ann Hepatol; 2015; 14(5):710-21. PubMed ID: 26256900
[TBL] [Abstract][Full Text] [Related]
20. Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.
Harris LLS; Smith GI; Mittendorfer B; Eagon JC; Okunade AL; Patterson BW; Klein S
J Clin Endocrinol Metab; 2017 Oct; 102(10):3858-3864. PubMed ID: 28938478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
